Efficacy of Music Therapy for Modifying Cardiovascular Disease

Despite the advancements in the treatment of many illnesses, cardiovascular disease (CVD) is still recognized as one of the most common causes of morbidity and mortality throughout the world. The annual number of fatalities caused by CVD is enormous, while its economic burden on society reaches hundreds of billions per year. Although drug-based and invasive therapeutic approaches continue to dominate in the clinical setting, there is an emerging trend towards exploring the potential value of alternative, non-pharmacological treatments such as music therapy in the cardiovascular disease management strategy. Thus, the purpose of the current paper is to explore the effectiveness of using music therapy in treating cardiovascular disease through analyzing evidence collected via randomized controlled trials, experimental studies, and observation studies. Research findings have revealed that slow-tempo music listening is capable of lowering heart rate, systolic blood pressure, pain, and anxiety in various patient samples: individuals under coronary angiography, cardiac valve replacement, and young adults with prehypertension. According to the results of the longitudinal analysis, frequent music listening may also be linked to the decreased CVD incidence in elderly people although the observed impact appears to be partly explained by other behavioral variables. Future research should prioritize large-scale longitudinal trials to establish optimal music therapy parameters and examine long-term cardiovascular outcomes. Music therapy represents a low-cost, accessible, and patient-centered complement to conventional cardiac care.